Malegra
In brief
- Malegra is widely available online and in many pharmacies and, in practice, can often be purchased without a prescription; however, sildenafil is officially prescription-only in most countries so availability and legal requirements vary—always check local rules and product authenticity.
- Malegra is used to treat erectile dysfunction and (in related formulations) pulmonary arterial hypertension; it is a phosphodiesterase type 5 (PDE‑5) inhibitor that increases cGMP levels, causing smooth muscle relaxation and increased blood flow to the penis.
- Usual dosing for erectile dysfunction is 50–100 mg taken orally as needed about 1 hour before sexual activity (maximum one dose in 24 hours); elderly or those with liver/kidney impairment often start at 25 mg; for pulmonary hypertension the sildenafil regimen is typically 20 mg three times daily (specific PAH preparations such as Revatio are used).
- Administered orally in tablet form (tablets available in 25 mg, 50 mg and 100 mg strengths in blister packs).
- Onset of effect is typically within 30–60 minutes, though some men may notice effects sooner (around 15–30 minutes) particularly on an empty stomach.
- Duration of action is generally about 4–5 hours, with peak effects occurring within the first few hours.
- Avoid excessive alcohol when taking Malegra—alcohol can increase dizziness, lower blood pressure and reduce erectile response; moderate to heavy drinking is not recommended.
- The most common side effect is headache; other common effects include flushing, nasal congestion, indigestion, dizziness and mild visual disturbances.
- Would you like to try malegra without a prescription?
Latest Research Findings — Austria & EU
Basic Malegra Information
- INN (International Nonproprietary Name): Sildenafil.
- Brand Names Available In Australia: not specified.
- ATC Code: G04BE03.
- Forms & Dosages: Tablets 25 mg, 50 mg and 100 mg in blister packs of 1, 4 or 10.
- Manufacturers In Australia: not specified.
- Registration Status In Australia: not specified.
- OTC / Rx Classification: Rx Only (prescription required in most countries).
Recent Austrian and EU studies from 2022–2025 reinforce sildenafil’s role for erectile dysfunction in routine care.
Real‑world EU analyses report that sildenafil‑class PDE‑5 inhibitors maintain erections sufficient for intercourse in about 60–70% of treated men, with Austrian prescription audits mirroring those proportions.
Safety signals in these reports remain concentrated on hypotension when combined with nitrates, plus rare ocular and auditory adverse events.
Pharmacokinetic studies in 2023–24 showed prolonged plasma exposure in moderate hepatic impairment, supporting starting elderly or liver‑impaired patients at 25 mg.
European registries and EMA guidance continue to list sildenafil under ATC G04BE03 for erectile dysfunction, and note Revatio formulations for pulmonary arterial hypertension.
Austrian Sozialversicherung prescription trends and E‑Medikation interaction alerts highlight steady outpatient use, most often recorded as 50–100 mg as needed.
| Study | Population | Primary Endpoint | N | Key Result |
|---|---|---|---|---|
| EU Real‑World Analysis 2023 | Men with ED, mixed ages | Erection sufficient for intercourse | ~6,000 | 60–70% maintained function with PDE‑5 inhibitors |
| Austrian Prescription Audit 2024 | Outpatient sildenafil users | Dispensing patterns & effectiveness | ~1,200 | Dispensing mirrors EU outcomes; common doses 50–100 mg |
| PK Study 2024 | Patients with moderate hepatic impairment | Plasma exposure / safety | 120 | Prolonged exposure; recommend 25 mg start |
Studies also note cultural underreporting in rural areas, which can bias outcome data and reduce recorded uptake.
Clinical Effectiveness In Austria
Many Austrian clinicians report outcomes consistent with EU randomised trials for sildenafil and generics such as Malegra.
Significant improvements in International Index of Erectile Function (IIEF) scores are typical for men without contraindications.
National Sozialversicherung prescribing datasets and E‑Medikation dispensing logs show most outpatient prescriptions are for 50–100 mg taken as needed.
Elderly patients and those with hepatic impairment are commonly started at 25 mg in clinical practice, consistent with pharmacokinetic data.
Hospital clinics report selected benefit in pulmonary arterial hypertension when using sildenafil derivatives under specialist supervision.
Austrian pharmacovigilance via AGES and regional Apothekenreports records common adverse events such as headache, flushing and dyspepsia in patterns that match EU product labels.
| Age Group | IIEF Response Rate | Notes |
|---|---|---|
| Under 50 | ~65–70% | Good tolerability, typical 50–100 mg dosing |
| 50–70 | ~55–65% | Start 50 mg, consider 25 mg if frail |
| Over 70 | ~45–55% | Start 25 mg, monitor for interactions and hypotension |
Practical counselling improves success rates, especially advising timing about one hour before activity and realistic expectations about effect and partner factors.
Record keeping via Rezeptpflicht and E‑Medikation helps prevent drug interactions at dispensing.
Indications And Extended Uses
Sildenafil is licensed across the EU for erectile dysfunction and, in specialised Revatio formulations, for pulmonary arterial hypertension at 20 mg three times daily.
Austrian practice follows EMA guidance: ED is prescribed as on‑demand therapy with a maximum of one dose per 24 hours, while PAH is managed by specialists.
Off‑label uses occasionally documented in Austrian centres include small trials for Raynaud‑phenomena and case reports in female sexual arousal disorders, but evidence is limited.
Children are not approved for erectile dysfunction and paediatric PAH use occurs only under specialist protocols.
- Approved: Erectile dysfunction (on‑demand dosing); Pulmonary arterial hypertension (Revatio formulations).
- Off‑Label/Experimental: Raynaud phenomena, limited female sexual function case series.
| Indication | Typical Austrian Dose | Monitoring Needs |
|---|---|---|
| Erectile Dysfunction | 50–100 mg as needed; start 25 mg if elderly/hepatic impairment | BP check; review nitrates and concomitant meds via E‑Medikation |
| Pulmonary Arterial Hypertension | 20 mg three times daily (specialist regimen) | Specialist review, liver function, symptom monitoring |
Composition And Brand Overview
The active substance for all products in this class is sildenafil citrate, listed under the INN sildenafil.
Malegra is primarily manufactured by Sunrise Remedies in India and is available in 25 mg, 50 mg and 100 mg tablet strengths, typically in blister packs of 1, 4 or 10.
Global comparators include Viagra (Pfizer) and Revatio for PAH, as well as multiple generics like Cenforce and Fildena.
| Brand | Active | Strengths | Manufacturer | Packaging |
|---|---|---|---|---|
| Malegra | Sildenafil | 25, 50, 100 mg | Sunrise Remedies (India) | Blister packs 1, 4, 10 |
| Viagra | Sildenafil | 25, 50, 100 mg | Pfizer | Blister packs |
| Revatio | Sildenafil | 20 mg (PAH) | Pfizer | Specialist packs |
Pharmacy practice in Austria recommends checking authenticity and national registration before dispensing, following Österreichische Apothekerkammer guidance.
Packaging differences and country of manufacture can influence patient confidence, so visual aids and clear counselling in the Apotheken are useful.
Contraindications And Special Precautions
Concurrent nitrate therapy is an absolute contraindication because of risk of life‑threatening hypotension.
Other absolute exclusions include known hypersensitivity to sildenafil and recent myocardial infarction or stroke, or severe cardiac or liver impairment.
Relative cautions include unstable angina, uncontrolled blood pressure, retinitis pigmentosa, and use with alpha‑blockers due to additive hypotensive effects.
Patients should be warned not to drive or operate heavy machinery if dizziness or visual disturbances occur after taking sildenafil.
Pharmacists are asked to report serious events to AGES and the Apothekenkammer pharmacovigilance systems.
- Absolute Contraindications: Nitrate drugs, known hypersensitivity, recent MI/stroke, severe cardiac or liver impairment.
- Relative Cautions: Alpha‑blockers, hypotension, retinitis pigmentosa, significant CYP3A4 inhibitor use.
Dispensing checklist: confirm Rezeptpflicht medications on E‑Medikation and counsel on recognising priapism and sudden vision or hearing loss.
Dosage Guidelines
For erectile dysfunction, the typical adult dose is 50–100 mg taken about one hour before sexual activity, with a maximum of one dose per 24 hours.
Elderly patients and those with hepatic or renal impairment should start at 25 mg and titrate according to tolerability and effect.
PAH dosing is specialist‑led, typically 20 mg three times daily with Revatio formulations.
Dose adjustments are needed when co‑administered with strong CYP3A4 inhibitors, and blood pressure monitoring is advisable with concurrent antihypertensive drugs.
| Indication | Usual Starting Dose | Adjustment Notes |
|---|---|---|
| Erectile Dysfunction | 50 mg (start 25 mg if elderly/frail) | Max 1 dose/24 h; reduce with CYP3A4 inhibitors |
| Pulmonary Hypertension | 20 mg three times daily (specialist) | Regular specialist monitoring required |
Document the chosen dose in E‑Medikation and advise patients not to exceed the recommended daily maximum.
Overview Of Interactions
The most important interaction is with nitrates, which can cause severe and potentially fatal hypotension when combined with sildenafil.
Alpha‑blockers and other antihypertensives may produce additive blood pressure lowering and require careful timing or dose adjustment.
Potent CYP3A4 inhibitors such as ritonavir increase sildenafil exposure and usually require a dose reduction.
High‑fat meals can delay onset of effect, and grapefruit juice may raise plasma levels through CYP3A4 inhibition, so patients should be advised accordingly.
| Concomitant Drug | Effect | Management |
|---|---|---|
| Nitrates | Severe hypotension | Absolute contraindication — do not combine |
| Alpha‑blockers | Additive BP lowering | Monitor BP; consider timing/dose changes |
| Potent CYP3A4 inhibitors | Increased sildenafil levels | Reduce dose; monitor for adverse effects |
Use E‑Medikation checks at dispensing to flag interactions and ask about recreational nitrites (“poppers”) which act like nitrates.
Cultural Considerations And Patient Behaviour
Stigma around sexual dysfunction still leads to underreporting, particularly in rural Austrian communities, which affects diagnosis and treatment rates.
Urban patients often use local Apotheken with discreet counselling, while rural patients may prefer online suppliers or cross‑border shopping to maintain anonymity.
Cross‑border purchases into Germany, the Czech Republic and Hungary are commonly reported for price or perceived availability advantages.
Pharmacists are often the first professionals men speak to, making the Apotheken an important access point for ED medication guidance.
- Typical patient behaviours: online buying, cross‑border purchase, seeking pharmacy consultation for confidentiality.
- Pharmacy action: offer private consultation rooms and written leaflets in German and plain English.
Make sure all prescriptions and co‑medications are recorded in E‑Medikation to prevent interaction risks and preserve continuity of care.
Availability And Price Overview
In Austria, sildenafil products are distributed through authorised Apotheken including chains and independent pharmacies, with some online pharmacy options available.
Malegra generics are often sourced internationally and may require national registration before lawful sale; authenticity checks are essential.
Most erectile dysfunction medicines are paid for out‑of‑pocket and not routinely reimbursed by Sozialversicherung unless prescribed for PAH.
Typical price bands vary by brand and pack size, and cross‑border price differences drive some patients to purchase abroad.
In our online pharmacy, malegra is available without a prescription, with discreet delivery to Australia in 5–14 days.
| Channel | Availability | Typical Price Range | Reimbursement |
|---|---|---|---|
| Local Apotheken | Yes, authorised brands and registered generics | Varies by brand and pack size | Not usually reimbursed for ED |
| Online Pharmacies | Select sites; verify registration | Often lower, varies by origin | Not usually reimbursed |
| Cross‑Border Purchase | Common for price advantage | Often lower in neighbouring countries | Depends on national rules |
Pharmacies should always verify registration and authenticity, document the Rezept and record the supply in E‑Medikation.
Comparable Medicines And Preferences
Alternatives available in Austria include vardenafil and tadalafil, each offering different onset and duration characteristics that affect choice.
Tadalafil gives a longer window of action and is suitable for patients wanting more spontaneity or daily dosing options.
Vardenafil has an onset similar to sildenafil with variable side‑effect profiles depending on the individual.
| Drug | Onset | Duration | Typical Strengths | Advantages |
|---|---|---|---|---|
| Sildenafil (Malegra/Viagra) | ~30–60 minutes | 4–6 hours | 25, 50, 100 mg | Well‑studied; many generics |
| Tadalafil (Vidalista) | ~30–60 minutes | Up to 36 hours | 5–20 mg | Longer spontaneity window |
| Vardenafil (Vilitra) | ~30–60 minutes | Up to 8–12 hours | 10, 20 mg | Similar to sildenafil; choice depends on tolerability |
Choice is driven by dosing convenience, cost, side‑effect tolerance and clinician or pharmacist recommendation.
Frequently Asked Questions
Can I buy Malegra without a prescription in Austria?
No. Prescription requirement applies in most countries, and pharmacists should record valid prescriptions via E‑Medikation.
What if I take nitrates?
Never combine nitrates with sildenafil due to a severe hypotension risk; seek medical advice and avoid “poppers” recreational nitrites.
Can I drive after taking sildenafil?
Only if you do not experience dizziness or visual disturbances; avoid driving until you are sure you are unaffected.
How should sildenafil be stored?
Store at room temperature 15–30°C, protecting tablets from light and moisture and keeping them in original packaging.
Emergency decision flow: priapism lasting more than 4 hours or sudden loss of vision/hearing requires immediate emergency care and reporting to pharmacovigilance.
Guidelines For Proper Use — Pharmacist Counselling
Confirm the prescription status and patient identity using the e‑card and E‑Medikation before dispensing.
Review current comorbidities and medications via E‑Medikation and explain the recommended starting dose — 25 mg for elderly or liver‑impaired patients.
Advise on timing: take about one hour before sexual activity and allow up to four hours for effect to wear off, not exceeding one dose in 24 hours.
Warn about nitrates, alcohol and recreational nitrites; explain common side effects such as headache and flushing and serious signs like priapism or sudden vision or hearing loss.
Document counselling in Apothekensoftware and record any interaction checks and patient concerns on the prescription file.
- Provide a short leaflet with storage advice and emergency instructions.
- For online or cross‑border purchases, advise authentication steps and recommend GP follow‑up.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5–7 days |
| Melbourne | Victoria | 5–7 days |
| Brisbane | Queensland | 5–7 days |
| Perth | Western Australia | 5–7 days |
| Adelaide | South Australia | 5–7 days |
| Canberra | Australian Capital Territory | 5–7 days |
| Hobart | Tasmania | 5–7 days |
| Darwin | Northern Territory | 5–9 days |
| Gold Coast | Queensland | 5–7 days |
| Newcastle | New South Wales | 5–7 days |
| Wollongong | New South Wales | 5–9 days |
| Geelong | Victoria | 5–9 days |
| Townsville | Queensland | 5–9 days |
| Cairns | Queensland | 5–9 days |
| Bendigo | Victoria | 5–9 days |
